Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19422140 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chromium Picolinate for the Treatment of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Prediabetic State;   Insulin Resistance;   Obesity;   Metabolic Diseases
Intervention: Drug: Chromium picolinate

Indicates status has not been verified in more than two years